The share issuance stems from the acquisition of Teyame AI LLC and a share exchange agreement with SecureKloud Technologies Ltd. By integrating these legacy deals, the Pleasanton-based firm has effectively bolstered its market capitalization to approximately $23.87 million, based on a July 28 closing price of $1.63 per share. This figure comfortably exceeds the $5 million minimum threshold recently approved by the U.S. Securities and Exchange Commission for all Nasdaq-listed companies.

David Ayanoglou, Chief Financial Officer of Healthcare Triangle, noted that completing these transactions serves as a vital component of the company's broader growth strategy while reinforcing its standing on the Nasdaq Global Market. While the increased share count provides a stronger compliance position, the company clarified that final determinations regarding listing status remain subject to ongoing Nasdaq assessments of daily closing bid prices and total shares listed.